SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-029642
Filing Date
2024-09-20
Accepted
2024-09-20 08:08:15
Documents
18
Period of Report
2024-09-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20240918_8k.htm   iXBRL 8-K 61463
2 EXHIBIT 2.1 ex_725605.htm EX-2.1 577471
3 EXHIBIT 2.2 ex_725701.htm EX-2.2 21277
4 EXHIBIT 99.1 ex_725905.htm EX-99.1 16624
9 logo.jpg GRAPHIC 3886
  Complete submission text file 0001437749-24-029642.txt   950550

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nby-20240919.xsd EX-101.SCH 3402
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240919_def.xml EX-101.DEF 11805
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240919_lab.xml EX-101.LAB 15859
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240919_pre.xml EX-101.PRE 12020
20 EXTRACTED XBRL INSTANCE DOCUMENT nby20240918_8k_htm.xml XML 2976
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 241311720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)